ProShare Advisors
GH icon

ProShare Advisors’s Guardant Health GH Stock Holding History

ProShare Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$705K Sell
4,701
-19,384
-80% -$2.11M ﹤0.01% 912
2026
Q1 		$2.22M Sell
24,085
-4,051
-14% -$407K ﹤0.01% 684
2025
Q4 		$2.87M Buy
28,136
+2,816
+11% +$252K 0.01% 658
2025
Q3 		$1.58M Sell
25,320
-4,328
-15% -$235K ﹤0.01% 723
2025
Q2 		$1.54M Sell
29,648
-2,327
-7% -$104K ﹤0.01% 715
2025
Q1 		$1.36M Sell
31,975
-7,619
-19% -$329K ﹤0.01% 737
2024
Q4 		$1.21M Buy
39,594
+9,268
+31% +$261K ﹤0.01% 839
2024
Q3 		$696K Buy
30,326
+6,885
+29% +$195K ﹤0.01% 949
2024
Q2 		$677K Sell
23,441
-5,876
-20% -$137K ﹤0.01% 845
2024
Q1 		$605K Buy
29,317
+2,518
+9% +$54K ﹤0.01% 978
2023
Q4 		$725K Buy
26,799
+4,161
+18% +$109K ﹤0.01% 850
2023
Q3 		$671K Buy
22,638
+300
+1% +$10.5K ﹤0.01% 807
2023
Q2 		$800K Buy
+22,338
New +$642K ﹤0.01% 777
2023
Q1 		– Sell
-10,026
Closed -$273K – 1841
2022
Q4 		$273K Sell
10,026
-198
-2% -$9.06K ﹤0.01% 1298
2022
Q3 		$551K Buy
10,224
+617
+6% +$31.7K ﹤0.01% 878
2022
Q2 		$387K Sell
9,607
-3,255
-25% -$161K ﹤0.01% 1070
2022
Q1 		$852K Sell
12,862
-4,004
-24% -$274K ﹤0.01% 982
2021
Q4 		$1.69M Sell
16,866
-7,173
-30% -$742K ﹤0.01% 806
2021
Q3 		$3M Buy
24,039
+2,744
+13% +$326K 0.01% 625
2021
Q2 		$2.65M Buy
21,295
+5,796
+37% +$780K 0.01% 667
2021
Q1 		$2.37M Sell
15,499
-1,457
-9% -$220K 0.01% 651
2020
Q4 		$2.19M Sell
16,956
-408
-2% -$46.9K 0.01% 621
2020
Q3 		$1.94M Buy
17,364
+1,410
+9% +$129K 0.01% 579
2020
Q2 		$1.29M Buy
15,954
+2,278
+17% +$184K 0.01% 643
2020
Q1 		$952K Sell
13,676
-7,595
-36% -$583K 0.01% 606
2019
Q4 		$1.66M Buy
+21,271
New +$1.53M 0.01% 658

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

ProShare Advisors's GH Position: Q2 2026 in Review

ProShare Advisors reduced its Guardant Health (GH) stake by 80% in Q2 2026, selling an estimated $2.11M and leaving 4,701 shares worth $705K. The position accounts for ﹤0.01% of the portfolio, ranked #912.

ProShare Advisors first reported a position in GH in Q4 2019 and has held it in 26 quarters since. The position peaked at $3M in Q3 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • ProShare Advisors held 4,701 shares of Guardant Health worth $705K as of Q2 2026.
  • ProShare Advisors sold 19,384 Guardant Health shares in Q2 2026, an estimated $2.11M.
  • Guardant Health made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #912 holding.
  • ProShare Advisors first reported a position in Guardant Health in Q4 2019 and has held it in 26 quarters since.
  • ProShare Advisors's Guardant Health position peaked at $3M in Q3 2021.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.